Cardiovascular and atherogenic aspects of subclinical hypothyroidism

Thyroid

Volumn 10, Issue 8, 2000, Pages 665-679

  Kahaly, G J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEVOTHYROXINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROID HORMONE;

ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PERFORMANCE; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; EXERCISE TEST; FEMALE; HEART FUNCTION; HEART MUSCLE REVASCULARIZATION; HEART RATE VARIABILITY; HIGH RISK POPULATION; HORMONE ACTION; HUMAN; HYPOTHYROIDISM; LIPID METABOLISM; LUNG FUNCTION TEST; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VASCULAR ENDOTHELIUM;

EID: 0033825444     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/10507250050137743     Document Type: Review

References (123)

1. Subclinical thyroid disease
2. The heart and thyroid disease
3. Subclinical hypothyroidism
4. Subclinical hypothyroidism
5. The aging thyroid. Increase prevalence of elevated serum thyrotropin levels in the elderly
6. American Thyroid Association guidelines for use of laboratory tests in thyroid disorders
7. Subclinical hypothyroidism
8. The spectrum of thyroid disease in a community: The Whickam Survey
9. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickam Survey
10. The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle-aged women: Association with serum lipids
11. Prevalence and follow-up of abnormal thyrotropin (TSH) concentrations in the elderly in the United Kingdom
12. Prevalence of subclinical thyroid failure in insulin-dependent diabetes
13. Prevalence of myxomatous mitral valve prolapse in patients with lymphocytic thyroiditis
14. Graves' disease and mitral valve prolapse
15. Subclinical hypothyroidism. Natural course of the syndrome during a prolonged follow-up study
16. Thyroid hormone and the cardiovascular system: From theory to practice
17. The cardiovascular system in hypothyroidism
18. Mechanism of edema formation in myxedema: Increased protein extravasation and relatively slow lymphatic drainage
19. Thyroid hormones and the heart: Basic mechanistic and clinical issues
20. The cardiovascular system in thyrotoxicosis
21. A paradigm of experimentally induced mild hyperthyroidism: Effects on nitrogen balance, body composition and energy expenditure in healthy young men
22. Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism
23. The Thyroid and the heart
24. Cardiovascular consequences of clinical and subclinical hypothyroidism
25. Non-invasive evaluation of cardiac function in hypothyroidism: Response to gradual thyroxine replacement
26. Myocardial function in hypothyroidism. Relation to disease severity and response to treatment
27. Peripheral responses to thyroid hormone before and after L-thyroxine therapy in patients with subclinical hypothyroidism
28. Systolic time intervals and ankle reflex time in patients with minimal serum TSH elevation: Response to triiodothyronine therapy
29. Hypothyroidism and the heart. Examination of left ventricular function in subclinical hypothyroidism
30. Spectrum of subclinical and overt hypothyroidism: Effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues
31. L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial
32. A double-blind cross-over 12-month study of L-thyroxine treatment of women with subclinical hypothyroidism
33. Left ventricular performance in subclinical hypothyroidism
34. End-organ responses to thyroxine therapy in subclinical hypothyroidism
35. Concurrent aortic and mitral valve echocardiography permits measurement of systolic time intervals as an index of peripheral tissue thyroid functional status
36. Cardiac systolic and diastolic function at rest and exercise in subclinical hypothyroidism: Effect of thyroid hormone therapy
37. Cardiovascular parameters in transitory hypothyroidism
38. Left ventricular function analyzed by Doppler and echocardiographic methods in short-term hypothyroidism
39. Stress echocardiography in hyperthyroidism
40. Impaired cardiopulmonary exercise capacity in hyperthyroidism
41. Ineffective cardiorespiratory function in hyperthyroidism
42. Components of heart rate variability - What they really mean and what we really measure
43. Cardiovascular neural regulation explored in the frequency domain
44. The significance of alteration in serum lipids in thyroid dysfunction. II. Alteration of the metabolism and turnover of 131I-low density lipoprotein in hypothyroidism and thyrotoxicosis
45. Thyroid dysfunction and hypercholesterolaemia in the general population of Glasgow, Scotland
46. Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia
47. Regulatory role of triiodothyronine in the degradation of low density lipoprotein by cultured human skin fibroblasts
48. Effects of hypothyroidism and high-fat feeding on mRNA concentrations for the low-density-lipoprotein receptor and on acyl-coA: Cholesterol acyltransferase activities in rat liver
49. Adrenergic regulation of lipolysis in human adipocytes: Findings in hyper- and hypothyroidism
50. Effect of thyroid dysfunction on high-density lipoprotein subfraction metabolism: Roles of hepatic lipase and cholesteryl ester transfer protein
51. Treatment of hypothyroidism reduces low-density lipoproteins but not lipoprotein (a)
52. Effect of thyroid function on concentrations of lipoprotein (a)
53. Long term thyroid replacement therapy and levels of lipoprotein (a) and other lipoproteins
54. The effect of treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins A-I, A-II and E
55. Thyroid hormones influence serum leptin concentrations in the rat
56. Thyroid hormones modulate serum leptin levels: Observations in thyrotoxic and hypothyroid women
57. Studies on subclinical hypothyroidism with special reference to the serum lipid pattern
58. Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein-lipase activity in overt and subclinical hypothyroidism: The effect of substitution therapy
59. Subclinical hypothyroidism and hyperlipoproteinaemia: Indiscriminate L-thyroxine treatment not justified
60. LDL/HDL-changes in subclinical, hypothyroidism: Possible risk factors for coronary heart disease
61. Decreased HDL cholesterol in subclinical hypothyroidism: The effect of L-thyroxine therapy
62. Circulating lipids and minor abnormalities of thyroid function
63. Thyroxine replacement therapy and circulating lipid concentrations
64. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of levothyroxine therapy
65. Disturbed lipid, metabolism in patients with subclinical hypothyroidism
66. Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein (a)
67. Elevated serum lipoprotein (a) in subclinical hypothyroidism
68. Impaired action of thyroid hormone associated with smoking in women with hypothyroidism
69. Relationship of cigarette smoking to blood pressure and serum lipids
70. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis
71. Evidence that selective endothelial dysfunction may occur in the abscence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis
72. Nitric oxide: An endogenous modulator of leucocyte adhesion
73. Myxedema and coronary artery disease: A comparative autopsy study
74. Flow-mediated, endothelium-dependent vasodilatation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values
75. Flow-induced release of endothelium-derived relaxing factor
76. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
77. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo
78. Atherosclerosis and the thyroid
79. Lipid profiles and cardiovascular disease in the Whickam area with particular reference to thyroid failure
80. Atrial natriuretic peptide in hypothyroidism
81. Effects of thyroid function on blood pressure
82. Preclinical hypothyroidism: A risk factor for coronary heart disease
83. Asymtomatic atrophic thyroiditis in coronary heart disease
84. Borderline low thyroid function and thyroid autoimmunity: Risk factors for coronary heart disease?
85. Increased mean serum thyrotropin in apparently euthyroid hypercholesterolemic patients: Does it mean occult hypothyroidism?
86. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an english community
87. Estimation of tissue hypothyroidism by a new clinical score: Evaluation of patients with various grades of hypothyroidism and controls
88. Subclinical thyroid dysfunction in the elderly 1994
89. Relationship of subclinical hypothyroidism to cardiovascular risk factors and disease in an elderly population
90. Screening for mild thyroid failure at the periodic health examination: A decision and cost-effectiveness analysis
91. Screening for thyroid disease: An update
92. Percutaneous transluminal coronary angioplasty in hypothyroidism
93. Outcome of percutaneous transluminal coronary angioplasty in patients with subclinical hypothyroidism
94. Complications of surgery in hypothyroid patients
95. Cardiovascular surgery in the hypothyroid patient
96. Outcome of anesthesia and surgery in hypothyroid patients
97. Thyroxine therapy in hypothyroid patients undergoing coronary revascularisation: A retrospective analysis
98. Treatment of heart disease associated with myxedema
99. The effect of thyroid hormone therapy on angiographic coronary artery disease progression
100. Hypothyroidism renders protection against lethal ventricular arrhythmias in a conscious canine model of sudden death
101. Deleterious influence of hypothyroidism on evolving myocardial infarction in conscious dogs
102. Thyroid hormone action: The mitochondrial pathway
103. Synthesis and degradation of myocardial protein during the development and regression of thyroxine-induced cardiac hypertrophy in rats
104. Catecholamine sensitivity, thyroid hormone and the heart: A reevaluation
105. Effects of thyroid hormones and cold exposure on turnover of norepinephrine in cardiac and skeletal muscle
106. Influence of thyroid state on the specific binding of noradrenaline to a cardiac particulate fraction and on catecholamine-sensitive cardiac adenylate cyclase activity
107. Thyroid hormone regulation of alpha-adrenergic receptors: Studies in rat myocardial
108. Decreased myocardial adenyl cyclase activity in hypothyroidism
109. Increased heart adenylcyclase activity in the hypothyroid rat
110. Thyroid hormone control of Na+-K+-ATPase and K+-dependent phosphatase in rat heart
111. The calcium pump of cardiac sarcoplasmic reticulum. Functional alterations at different levels of thyroid state in rabbits
112. Stimulation of cardiac myosin adenosine triphosphatase in thyrotoxicosis
113. Thyroid state and the activity of glycogen phosphorylase in ischemic myocardium
114. Thyroid hormone action at the cell level
115. The influence of hyperthyroidism and hypothyroidism on the wound healing of experimental myocardial infarction in the rat
116. Coronary artery disease in hypothyroidism
117. Serum myoglobin level in altered thyroid states
118. Catecholamine metabolism in thyroid disease I. Epinephrine secretion rate in hyperthyroidism and hypothyroidism
119. Catecholamine metabolism in thyroid disease II. Norepinephrine secretion rate in hyperthyroidism and hypothyroidism
120. Subclinical hypothyroidism in the elderly: To treat or not to treat
121. Cardiac risks of hyperthyroidism in the elderly
122. The aging thyroid. The use of thyroid hormone in older persons
123. Treatment guidelines for patients with hyperthyroidism and hypothyroidism